FEP knows many of you have serious concerns and questions regarding COVID-19 (coronavirus), especially as this outbreak continues to significantly impact our daily lives.

Our coverage commitment is to ensure our members can swiftly access the right care at the right time during the outbreak.

We’re Here For You

During this time, these resources can help you stay informed and get the care you need.

Questions about your benefits Call the National Information Center at 1-800-411-BLUE (2583), weekdays from 8 a.m. to 8 p.m. Eastern Time.

Questions about your health Call our 24/7 Nurse Line at 1-888-258-3432 to speak to a registered nurse. Get answers for any health-related questions, including advice on where to seek treatment for COVID-19.

Connect with a virtual doctor For members who are sick and need to stay home, telehealth services are also available. FEP will waive copays for all virtual doctor visits by Teladoc®. You can easily set up your account here or by calling 1-855-636-1579. The fastest way to get care with telehealth is by using the Teladoc app or online.

Get more resources from MyBlue® Sign up for MyBlue and use the fepblue mobile app to get access to additional tools and programs. These include wellness resources from WebMD, such as the Blue Health Assessment and Online Health Coach.

Find a Preferred provider You can use our Find a Doctor tool to search for doctors and facilities near you. Any members who are overseas can search for providers here.


To ensure you have access to the right care at the right time, FEP is waiving cost shares and prior authorization to support members’ care for COVID-19. They include:

  1. FEP will waive prior authorizations for diagnostic tests and for covered services that are medically necessary and consistent with CDC guidance if diagnosed with COVID-19. FEP will also make dedicated clinical staff available to address inquiries related to medical services, ensuring timeliness of responses related to COVID-19.

  2. Similarly, FEP will waive any cost-share for diagnostic tests or treatment that are medically necessary and consistent with CDC guidance if diagnosed with COVID-19. FEP will cover, with no cost share to the member, the appropriate medically necessary diagnostic testing for COVID-19, where it is not covered as part of the Public Health Service response. FEP will waive any copays, coinsurance, or deductibles for treatment, eliminating barriers to treatment and reducing the risk of spreading the virus further.

  3. FEP will increase access to prescription medications by waiving early medication refill limits on 30-day prescription maintenance medications. FEP will also encourage members to use 90-day mail order benefit. FEP will also ensure formulary flexibility if there are shortages or access issues. Patients will not be liable for the additional charges that stem from obtaining a non-preferred medication when a formulary drug is not available due to shortage or access issues.

  4. FEP will also eliminate any cost share for prescriptions up to a 30-day supply. Eliminating any barriers to members that receive a prescription as part of their treatment for COVID-19 will further increase recovery and reduce the risk of spreading the virus further.

  5. FEP will waive copays for all telehealth services provided by Teladoc®. Given the nature of the COVID-19 epidemic, seeking in-person medical care may lead to further spreading of the virus. FEP will encourage the use of virtual care and will also facilitate member access.

To read FEP’s full official statement regarding COVID-19, please click here.

Page updated on March 27, 2020.

Real-time Updates

See how the Centers for Disease Control and Prevention (CDC) is closely monitoring the COVID-19 outbreak.

Learn More

Coronavirus Resource Center

Johns Hopkins University has resources to help you learn more about the disease.
Read More

Stay Informed

Get the latest information from the Blue Cross Blue Shield Association.
Read More

We use cookies on this website to give you the best experience and measure website usage. By continuing to use this website, you consent to these cookies.
For more information, view our privacy policy.